SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SHENZHEN, China, Dec. 16, 2025 /PRNewswire/ -- iGreen Think Tank, an independent research institution specializing in sustainable development and ESG evaluation, has released its latest...
HONG KONG, Dec. 16, 2025 /PRNewswire/ -- Luda Technology Group Limited and its subsidiaries ("Luda Technology" or the "Company", NYSE: LUD.US) announced that its strategic equity investment...
SEOUL, SOUTH KOREA, Dec. 16, 2025 /PRNewswire/ -- The Global Digital Innovation Network (GDIN), in collaboration with the Ministry of Science and ICT (MSIT)...